Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemic Outpatients With or Without Gout
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2018
Price : $35 *
At a glance
- Drugs Dotinurad (Primary)
- Indications Hyperuricaemia
- Focus Pharmacodynamics; Registrational
- Sponsors Mochida Pharmaceutical
- 21 Sep 2018 Status changed from recruiting to completed.
- 23 Jan 2018 Status changed from not yet recruiting to recruiting.
- 28 Dec 2017 New trial record